Remove Bioavailability Remove Marketing Remove Research
article thumbnail

Bioavailability Enhancement Technologies

Roots Analysis

Moreover, it is a well-established fact that the systemic / local absorption and distribution of a therapeutic intervention is directly proportional to its bioavailability. Technology evaluation framework provides a value addition matrix for bioavailability enhancement approaches currently employed by industry stakeholders.

article thumbnail

Betta to commercialise C4 Therapeutics’ CFT8919 in greater China

Pharmaceutical Technology

It is expected to accelerate the development of CFT8919 in important international markets. CFT8919 is an orally bioavailable BiDAC degrader designed to exhibit potent and selective activity against EGFR L858R in patients with non-small cell lung cancer (NSCLC).

In-Vivo 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Synthesis-to-Clinic®: integrating isotopic labeling and human ADME to reduce time to clinic

Pharmaceutical Technology

Understanding how a drug will act in the body, including how it is absorbed, distributed, and eventually eliminated, is a crucial component of drug research. Well-planned ADME investigations are conducted in the early stages of clinical research to generate this important data, which is needed for regulatory submissions.

article thumbnail

The Composition and Value of a Portfolio Analysis

Camargo

In addition, the size and complexity of a development program can vary significantly depending on product characteristics, market dynamics, and regulatory pathway. Pediatric Research Equity Act (PREA) Requirements. It can also help identify which of these factors are most critical to commercial success. Biowaiver Eligibility.

article thumbnail

Nanomilling: How the latest Dynamic Light Scattering (DLS) technology could revolutionise hydrophobic API production

Pharmaceutical Technology

This question forms the basis of a new scientific research paper, Nanomilling and size characterization of highly concentrated API suspensions from Fribourg University, Switzerland, which details experiments using nanomilling techniques to reduce micron sized particles further down to nanometric size, thus useful for the pharmaceutical industry.

article thumbnail

EverGrain’s Line of Barley-Based Products Scores Upcycled Certification

XTalks

After five years of research and development, the brand found a way to transform saved grain from brewing into nutrient-rich, barley-based proteins and fibers that have a variety of applications in the food and beverage industry. billion by 2027 at a compound annual growth rate (CAGR) of two percent, according to Research and Markets.

article thumbnail

PROTACs show promise for cancer treatment

Pharmaceutical Technology

According to a whitepaper from contract research, development and manufacturing organisation Syngene, PROTACs are effective against “undruggable” targets such as transcription factors, and scaffolding proteins that cannot be otherwise targeted by the traditional small molecule inhibitors.

Protein 130